Brian Moore, MD
Surgery · la Porte, INNPI 1205942075
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 18 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Bayer at 24.8% of the total. Reporting peaked in 2022 at $151 and has fallen 61.0% since, to $59 in 2025. That places this record below the midpoint for surgery clinicians in IN, where the typical reported total is $1,566.
Across 18 payments — averaging $22.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$101
- Boston Scientific$73
- Sanara Medtech Inc.$35
- Smith+Nephew$29
- Sanofi-aventis U.S. LLC$26
- Lilly USA, LLC$23
- plus $120 from 7 others
What the payments were for
- Food & beverage$407100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 6 | $101 |
| Boston Scientific | 1 | $73 |
| Sanara Medtech Inc. | 1 | $35 |
| Smith+Nephew | 1 | $29 |
| Sanofi-aventis U.S. LLC | 1 | $26 |
| Lilly USA, LLC | 1 | $23 |
| Johnson & Johnson | 1 | $21 |
| AbbVie | 1 | $21 |
| Pfizer | 1 | $20 |
| Exact Sciences | 1 | $17 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $14 |
| Boehringer Ingelheim | 1 | $14 |
| Paratek Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$407 in reported general payments places this provider in the 25th percentile of 524 surgery providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 28 | $186 |
Paid to pharmacies, not to this prescriber.
Other surgery in la Porte
- Jeremy Luedtkela Porte$102K
- Christopher Connla Porte$16K
- Paul SzotekIndianapolis$2.4M
- Carlos Gonzalez RendonMunster$275K
- Anthony ZappiaCarmel$105K
- Patricia ClarkFort Wayne$82K
- Erica GiblinCarmel$70K
- Paul BowldsGreenwood$69K
- Michael MillerIndianapolis$53K
- M ShabeebMunster$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.